Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
CollPlant Biotechnologies Community
NasdaqGM:CLGN Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Community Investing Ideas
CollPlant Biotechnologies
Popular
Undervalued
Overvalued
CollPlant Biotechnologies
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Expanding Distribution And Pipeline Advances Will Open New Markets
Key Takeaways Expanding distribution channels and promising product development are poised to drive future revenue growth and market potential. Strategic collaborations and innovative technologies could unlock significant revenue opportunities and milestone payments.
View narrative
US$12.00
FV
79.5% undervalued
intrinsic discount
59.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
CLGN
CLGN
CollPlant Biotechnologies
Your Fair Value
US$
Current Price
US$2.47
22.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-17m
20m
2015
2018
2021
2024
2025
2027
2030
Revenue US$10.4m
Earnings US$2.2m
Advanced
Set Fair Value